Yesterday was a big step for the Modernizing and Ensuring PBM Accountability Act, a PBM reform package supported by NCPA, which advanced in a bipartisan vote of 26-1 to a vote of the full Senate. The package contains several provisions to enhance transparency into PBM-insurer operations, improve patient access to community pharmacies, and ensure fair pharmacy reimbursements that are based on actual acquisition and dispensing costs. After a full Senate vote, the next stop would be consideration by the House of Representatives, although that timeline is unclear at this time. The package, sponsored by Senate Finance Committee Chairman Ron Wyden (D-Ore.) and Ranking Member Mike Crapo (R-Idaho), also contains language from two NCPA-backed bills: the Drug Price Transparency in Medicaid Act (S. 1038), which creates a fairer reimbursement rate for pharmacies operating in Medicaid managed care, and the Protect Patient Access to Pharmacies Act (S. 2052), which reforms Medicare Part D by clarifying and providing enforcement tools for the any willing pharmacy law. Learn more by reading NCPA’s press release.
NCPA
